September 20th 2024
Peptides are increasingly used in cosmeceuticals for their ability to enhance cellular communication and functionality in antiaging formulations.
Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)
View More
Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia
View More
Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis
November 21, 2024 - December 5, 2024
View More
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis
View More
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
View More
Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis
View More
Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis
View More
Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Is Parental Consent Valid for Minor Children?
December 15th 2002Anew oral retinoid has been FDA cleared for the treatment of psoriasis. It has been shown to be safer than all previously available retinoids. Dr. Doe learned that this medication has been used safely in Europe for the prevention of acne in pre-adolescent teenagers. He has a large adolescent practice and is excited about using this medication on his young patients. Recognizing that the drug does not have FDA clearance for his intended use, he asks parents of prospective patients to sign a consent form allowing him to use this potentially miraculous drug on their children. Is the consent of the parent valid?
Silenced Silicone Needs FDA Signature
December 15th 2002A decade has passed since the FDA prohibited the use of injectable silicon for cosmetic purposes after complaints were made that leaking silicone breast implants caused a variety of autoimmune ailments, and that the migration of silicone in facial cosmetic use caused granulomas and permanent swelling.
New Applications Put Derm Surgery in Strong Position
November 15th 2002Zoe Diana Draelos, M.D., clinical associate professor, department of dermatology, Wake Forest University School of Medicine, and William P. Coleman III, M.D., editor, Journal of Dermatologic Surgery, discuss advances in dermatologic surgery.
Pain control crucial when using RF
October 1st 2002Atlanta - A radiofrequency device for aesthetic and therapeutic applications has the potential to revolutionize cosmetic surgery, but pain control measures must be a high priority for the device to be used at an effective fluence, said Richard E. Fitzpatrick, M.D., of Dermatology Associates/Cosmetic Laser Associates of San Diego County.
Vitamin cosmeceuticals gain popularity, performance varies
October 1st 2002Chicago -- Prescription and nonprescription forms of vitamin cosmeceuticals are gaining in popularity among patients. While research is lacking in this unregulated industry, available studies and experience seem to indicate that some vitamin ingredients show more benefit than others, Zoe Diana Draelos, M.D., said at the International Symposium on Aging Skin.
Fat rebalancing more natural alternative to lifts
October 1st 2002New Orleans - Restoring the primary structural arcs of the face through facial fat rebuilding is a more effective alternative to conventional cosmetic surgery of the aging face, Lisa M. Donofrio, M.D., said at the annual meeting of the American Academy of Dermatology.
Contact, dynamic cooling systems comparable
October 1st 2002Atlanta - Treatment of leg veins and telangiectasias with a 1064nm Nd:YAG laser is slightly more comfortable using an instrument featuring dynamic cooling compared with one having contact cooling, but either type of system is a good choice for safe and effective vessel clearance in patients with light as well as darker skin types, Leyda Bowes, M.D., said at the annual meeting of the American Society for Laser Medicine and Surgery.
Physicians offer cosmetic discounts to HMO members
October 1st 2002Columbia, S.C. - Two well-established cosmetic surgery practices in South Carolina are offering discounted cosmetic procedures to the 1.2 million members of Blue Cross Blue Shield of South Carolina, the state's largest managed care plan. The discounts will average about 20 percent for eight common procedures. Botulinum toxin (Botox) treatment, for instance, will cost $175 for one area after the discount.